Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is one of six main centers for the U.S. Food and Drug Administration, which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Center for Biologics Evaluation and Research, United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
62%
Total
Publications
4.7K
Total Open
Publications
2.9K
Total
Citations
206K
Open Access
Percentage
62%
Total
Publications
4.7K
Total Open
Publications
2.9K
Total
Citations
206K
Breakdown
Publisher Open
15%
Both
32%
Other Platform Open
15%
Closed
38%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
824
Hybrid 23%
504
No Guarantees 40%
875
Other Platform Open
Domain 93%
2K
Public 12%
271
Institution 12%
265
Preprint 7%
146
Other Internet 6%
131
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 2K |
Europe PMC | Domain | 1.5K |
Semantic Scholar | Public | 238 |
bioRxiv | Preprint | 94 |
DOI | Other Internet | 64 |
Figshare | Public | 41 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 37 |
medRxiv | Preprint | 29 |
CiteSeer X | Other Internet | 28 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 20 |